Total Funding
20
6
Total FundingPost-IPO Equity raised
Growth Score
-12 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
439348
Champions Oncology develops advanced technology solutions and services for personalizing the development and use of oncology drugs.
- Michael Ritchie: CCO
- Ronnie Morris: Executive ChairmanPast Role: MDVIP, Co-Founder
About the Company
Champions Oncology was founded by some of the world’s most renowned specialists in the field of cancer diagnosis, treatment, and research. Our team is comprised of seasoned oncology professionals passionately dedicated to working with you to accelerate oncology drug development, improve outcomes and extend lives. Our core platform, the Champions
TumorGraft™ offers an enhanced xenograft mouse avatar model for growing and testing human tumors.
